Summary

The global Osteoarthritis Analgesics market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Osteoarthritis is an inflammatory disease, and pain is closely related to inflammation. Analgesic drugs for osteoarthritis are mainly divided into two categories: over-the-counter drugs and prescription drugs. There are three main types: injection, oral and topical.
United States market for Osteoarthritis Analgesics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Osteoarthritis Analgesics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Osteoarthritis Analgesics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Osteoarthritis Analgesics players cover Pfizer, Bayer, Johnson & Johnson, Sanofi, Abbott, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Osteoarthritis Analgesics Industry Forecast” looks at past sales and reviews total world Osteoarthritis Analgesics sales in 2024, providing a comprehensive analysis by region and market sector of projected Osteoarthritis Analgesics sales for 2025 through 2031. With Osteoarthritis Analgesics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Osteoarthritis Analgesics industry.
This Insight Report provides a comprehensive analysis of the global Osteoarthritis Analgesics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Osteoarthritis Analgesics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Osteoarthritis Analgesics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Osteoarthritis Analgesics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Osteoarthritis Analgesics.
This report presents a comprehensive overview, market shares, and growth opportunities of Osteoarthritis Analgesics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Injections
Oral Medications
Topical Medications
Segmentation by Application:
Hospital
Personal
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Pfizer
Bayer
Johnson & Johnson
Sanofi
Abbott
GlaxoSmithKline
TEVA
Almatica Pharma
Astellas Pharma
Iroko Pharmaceuticals
SK Chemicals
Eli Lilly
Crystal Genomics
Synartro
Mikasa Seiyaku
Daiichi Sankyo
Taisho Pharmaceutical
Sino Biopharmaceutical
Seikagaku
Novartis
Horizon Pharma
Mylan
Abiogen Pharma
Shanghai Haohai Biological Technology
Zhejiang ChengYi Pharmaceutical
Jiangsu Hengrui Medicine
Hunan Jingfeng Pharmaceutical
Beijing Tide Pharmaceutical
Jiangsu Simcere Pharmaceutical
Cspc Holdings
Concentric Analgesics
Key Questions Addressed in this Report
What is the 10-year outlook for the global Osteoarthritis Analgesics market?
What factors are driving Osteoarthritis Analgesics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Osteoarthritis Analgesics market opportunities vary by end market size?
How does Osteoarthritis Analgesics break out by Type, by Application?

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Osteoarthritis Analgesics Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Osteoarthritis Analgesics by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Osteoarthritis Analgesics by Country/Region, 2020, 2024 & 2031
2.2 Osteoarthritis Analgesics Segment by Type
2.2.1 Injections
2.2.2 Oral Medications
2.2.3 Topical Medications
2.3 Osteoarthritis Analgesics Sales by Type
2.3.1 Global Osteoarthritis Analgesics Sales Market Share by Type (2020-2025)
2.3.2 Global Osteoarthritis Analgesics Revenue and Market Share by Type (2020-2025)
2.3.3 Global Osteoarthritis Analgesics Sale Price by Type (2020-2025)
2.4 Osteoarthritis Analgesics Segment by Application
2.4.1 Hospital
2.4.2 Personal
2.4.3 Others
2.5 Osteoarthritis Analgesics Sales by Application
2.5.1 Global Osteoarthritis Analgesics Sale Market Share by Application (2020-2025)
2.5.2 Global Osteoarthritis Analgesics Revenue and Market Share by Application (2020-2025)
2.5.3 Global Osteoarthritis Analgesics Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Osteoarthritis Analgesics Breakdown Data by Company
3.1.1 Global Osteoarthritis Analgesics Annual Sales by Company (2020-2025)
3.1.2 Global Osteoarthritis Analgesics Sales Market Share by Company (2020-2025)
3.2 Global Osteoarthritis Analgesics Annual Revenue by Company (2020-2025)
3.2.1 Global Osteoarthritis Analgesics Revenue by Company (2020-2025)
3.2.2 Global Osteoarthritis Analgesics Revenue Market Share by Company (2020-2025)
3.3 Global Osteoarthritis Analgesics Sale Price by Company
3.4 Key Manufacturers Osteoarthritis Analgesics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Osteoarthritis Analgesics Product Location Distribution
3.4.2 Players Osteoarthritis Analgesics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Osteoarthritis Analgesics by Geographic Region
4.1 World Historic Osteoarthritis Analgesics Market Size by Geographic Region (2020-2025)
4.1.1 Global Osteoarthritis Analgesics Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Osteoarthritis Analgesics Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Osteoarthritis Analgesics Market Size by Country/Region (2020-2025)
4.2.1 Global Osteoarthritis Analgesics Annual Sales by Country/Region (2020-2025)
4.2.2 Global Osteoarthritis Analgesics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Osteoarthritis Analgesics Sales Growth
4.4 APAC Osteoarthritis Analgesics Sales Growth
4.5 Europe Osteoarthritis Analgesics Sales Growth
4.6 Middle East & Africa Osteoarthritis Analgesics Sales Growth
5 Americas
5.1 Americas Osteoarthritis Analgesics Sales by Country
5.1.1 Americas Osteoarthritis Analgesics Sales by Country (2020-2025)
5.1.2 Americas Osteoarthritis Analgesics Revenue by Country (2020-2025)
5.2 Americas Osteoarthritis Analgesics Sales by Type (2020-2025)
5.3 Americas Osteoarthritis Analgesics Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Osteoarthritis Analgesics Sales by Region
6.1.1 APAC Osteoarthritis Analgesics Sales by Region (2020-2025)
6.1.2 APAC Osteoarthritis Analgesics Revenue by Region (2020-2025)
6.2 APAC Osteoarthritis Analgesics Sales by Type (2020-2025)
6.3 APAC Osteoarthritis Analgesics Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Osteoarthritis Analgesics by Country
7.1.1 Europe Osteoarthritis Analgesics Sales by Country (2020-2025)
7.1.2 Europe Osteoarthritis Analgesics Revenue by Country (2020-2025)
7.2 Europe Osteoarthritis Analgesics Sales by Type (2020-2025)
7.3 Europe Osteoarthritis Analgesics Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Osteoarthritis Analgesics by Country
8.1.1 Middle East & Africa Osteoarthritis Analgesics Sales by Country (2020-2025)
8.1.2 Middle East & Africa Osteoarthritis Analgesics Revenue by Country (2020-2025)
8.2 Middle East & Africa Osteoarthritis Analgesics Sales by Type (2020-2025)
8.3 Middle East & Africa Osteoarthritis Analgesics Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Osteoarthritis Analgesics
10.3 Manufacturing Process Analysis of Osteoarthritis Analgesics
10.4 Industry Chain Structure of Osteoarthritis Analgesics
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Osteoarthritis Analgesics Distributors
11.3 Osteoarthritis Analgesics Customer
12 World Forecast Review for Osteoarthritis Analgesics by Geographic Region
12.1 Global Osteoarthritis Analgesics Market Size Forecast by Region
12.1.1 Global Osteoarthritis Analgesics Forecast by Region (2026-2031)
12.1.2 Global Osteoarthritis Analgesics Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Osteoarthritis Analgesics Forecast by Type (2026-2031)
12.7 Global Osteoarthritis Analgesics Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Osteoarthritis Analgesics Product Portfolios and Specifications
13.1.3 Pfizer Osteoarthritis Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Osteoarthritis Analgesics Product Portfolios and Specifications
13.2.3 Bayer Osteoarthritis Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson Osteoarthritis Analgesics Product Portfolios and Specifications
13.3.3 Johnson & Johnson Osteoarthritis Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 Sanofi
13.4.1 Sanofi Company Information
13.4.2 Sanofi Osteoarthritis Analgesics Product Portfolios and Specifications
13.4.3 Sanofi Osteoarthritis Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Sanofi Main Business Overview
13.4.5 Sanofi Latest Developments
13.5 Abbott
13.5.1 Abbott Company Information
13.5.2 Abbott Osteoarthritis Analgesics Product Portfolios and Specifications
13.5.3 Abbott Osteoarthritis Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Abbott Main Business Overview
13.5.5 Abbott Latest Developments
13.6 GlaxoSmithKline
13.6.1 GlaxoSmithKline Company Information
13.6.2 GlaxoSmithKline Osteoarthritis Analgesics Product Portfolios and Specifications
13.6.3 GlaxoSmithKline Osteoarthritis Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 GlaxoSmithKline Main Business Overview
13.6.5 GlaxoSmithKline Latest Developments
13.7 TEVA
13.7.1 TEVA Company Information
13.7.2 TEVA Osteoarthritis Analgesics Product Portfolios and Specifications
13.7.3 TEVA Osteoarthritis Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 TEVA Main Business Overview
13.7.5 TEVA Latest Developments
13.8 Almatica Pharma
13.8.1 Almatica Pharma Company Information
13.8.2 Almatica Pharma Osteoarthritis Analgesics Product Portfolios and Specifications
13.8.3 Almatica Pharma Osteoarthritis Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Almatica Pharma Main Business Overview
13.8.5 Almatica Pharma Latest Developments
13.9 Astellas Pharma
13.9.1 Astellas Pharma Company Information
13.9.2 Astellas Pharma Osteoarthritis Analgesics Product Portfolios and Specifications
13.9.3 Astellas Pharma Osteoarthritis Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Astellas Pharma Main Business Overview
13.9.5 Astellas Pharma Latest Developments
13.10 Iroko Pharmaceuticals
13.10.1 Iroko Pharmaceuticals Company Information
13.10.2 Iroko Pharmaceuticals Osteoarthritis Analgesics Product Portfolios and Specifications
13.10.3 Iroko Pharmaceuticals Osteoarthritis Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Iroko Pharmaceuticals Main Business Overview
13.10.5 Iroko Pharmaceuticals Latest Developments
13.11 SK Chemicals
13.11.1 SK Chemicals Company Information
13.11.2 SK Chemicals Osteoarthritis Analgesics Product Portfolios and Specifications
13.11.3 SK Chemicals Osteoarthritis Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 SK Chemicals Main Business Overview
13.11.5 SK Chemicals Latest Developments
13.12 Eli Lilly
13.12.1 Eli Lilly Company Information
13.12.2 Eli Lilly Osteoarthritis Analgesics Product Portfolios and Specifications
13.12.3 Eli Lilly Osteoarthritis Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Eli Lilly Main Business Overview
13.12.5 Eli Lilly Latest Developments
13.13 Crystal Genomics
13.13.1 Crystal Genomics Company Information
13.13.2 Crystal Genomics Osteoarthritis Analgesics Product Portfolios and Specifications
13.13.3 Crystal Genomics Osteoarthritis Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Crystal Genomics Main Business Overview
13.13.5 Crystal Genomics Latest Developments
13.14 Synartro
13.14.1 Synartro Company Information
13.14.2 Synartro Osteoarthritis Analgesics Product Portfolios and Specifications
13.14.3 Synartro Osteoarthritis Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Synartro Main Business Overview
13.14.5 Synartro Latest Developments
13.15 Mikasa Seiyaku
13.15.1 Mikasa Seiyaku Company Information
13.15.2 Mikasa Seiyaku Osteoarthritis Analgesics Product Portfolios and Specifications
13.15.3 Mikasa Seiyaku Osteoarthritis Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Mikasa Seiyaku Main Business Overview
13.15.5 Mikasa Seiyaku Latest Developments
13.16 Daiichi Sankyo
13.16.1 Daiichi Sankyo Company Information
13.16.2 Daiichi Sankyo Osteoarthritis Analgesics Product Portfolios and Specifications
13.16.3 Daiichi Sankyo Osteoarthritis Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Daiichi Sankyo Main Business Overview
13.16.5 Daiichi Sankyo Latest Developments
13.17 Taisho Pharmaceutical
13.17.1 Taisho Pharmaceutical Company Information
13.17.2 Taisho Pharmaceutical Osteoarthritis Analgesics Product Portfolios and Specifications
13.17.3 Taisho Pharmaceutical Osteoarthritis Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Taisho Pharmaceutical Main Business Overview
13.17.5 Taisho Pharmaceutical Latest Developments
13.18 Sino Biopharmaceutical
13.18.1 Sino Biopharmaceutical Company Information
13.18.2 Sino Biopharmaceutical Osteoarthritis Analgesics Product Portfolios and Specifications
13.18.3 Sino Biopharmaceutical Osteoarthritis Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Sino Biopharmaceutical Main Business Overview
13.18.5 Sino Biopharmaceutical Latest Developments
13.19 Seikagaku
13.19.1 Seikagaku Company Information
13.19.2 Seikagaku Osteoarthritis Analgesics Product Portfolios and Specifications
13.19.3 Seikagaku Osteoarthritis Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Seikagaku Main Business Overview
13.19.5 Seikagaku Latest Developments
13.20 Novartis
13.20.1 Novartis Company Information
13.20.2 Novartis Osteoarthritis Analgesics Product Portfolios and Specifications
13.20.3 Novartis Osteoarthritis Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.20.4 Novartis Main Business Overview
13.20.5 Novartis Latest Developments
13.21 Horizon Pharma
13.21.1 Horizon Pharma Company Information
13.21.2 Horizon Pharma Osteoarthritis Analgesics Product Portfolios and Specifications
13.21.3 Horizon Pharma Osteoarthritis Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.21.4 Horizon Pharma Main Business Overview
13.21.5 Horizon Pharma Latest Developments
13.22 Mylan
13.22.1 Mylan Company Information
13.22.2 Mylan Osteoarthritis Analgesics Product Portfolios and Specifications
13.22.3 Mylan Osteoarthritis Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.22.4 Mylan Main Business Overview
13.22.5 Mylan Latest Developments
13.23 Abiogen Pharma
13.23.1 Abiogen Pharma Company Information
13.23.2 Abiogen Pharma Osteoarthritis Analgesics Product Portfolios and Specifications
13.23.3 Abiogen Pharma Osteoarthritis Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.23.4 Abiogen Pharma Main Business Overview
13.23.5 Abiogen Pharma Latest Developments
13.24 Shanghai Haohai Biological Technology
13.24.1 Shanghai Haohai Biological Technology Company Information
13.24.2 Shanghai Haohai Biological Technology Osteoarthritis Analgesics Product Portfolios and Specifications
13.24.3 Shanghai Haohai Biological Technology Osteoarthritis Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.24.4 Shanghai Haohai Biological Technology Main Business Overview
13.24.5 Shanghai Haohai Biological Technology Latest Developments
13.25 Zhejiang ChengYi Pharmaceutical
13.25.1 Zhejiang ChengYi Pharmaceutical Company Information
13.25.2 Zhejiang ChengYi Pharmaceutical Osteoarthritis Analgesics Product Portfolios and Specifications
13.25.3 Zhejiang ChengYi Pharmaceutical Osteoarthritis Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.25.4 Zhejiang ChengYi Pharmaceutical Main Business Overview
13.25.5 Zhejiang ChengYi Pharmaceutical Latest Developments
13.26 Jiangsu Hengrui Medicine
13.26.1 Jiangsu Hengrui Medicine Company Information
13.26.2 Jiangsu Hengrui Medicine Osteoarthritis Analgesics Product Portfolios and Specifications
13.26.3 Jiangsu Hengrui Medicine Osteoarthritis Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.26.4 Jiangsu Hengrui Medicine Main Business Overview
13.26.5 Jiangsu Hengrui Medicine Latest Developments
13.27 Hunan Jingfeng Pharmaceutical
13.27.1 Hunan Jingfeng Pharmaceutical Company Information
13.27.2 Hunan Jingfeng Pharmaceutical Osteoarthritis Analgesics Product Portfolios and Specifications
13.27.3 Hunan Jingfeng Pharmaceutical Osteoarthritis Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.27.4 Hunan Jingfeng Pharmaceutical Main Business Overview
13.27.5 Hunan Jingfeng Pharmaceutical Latest Developments
13.28 Beijing Tide Pharmaceutical
13.28.1 Beijing Tide Pharmaceutical Company Information
13.28.2 Beijing Tide Pharmaceutical Osteoarthritis Analgesics Product Portfolios and Specifications
13.28.3 Beijing Tide Pharmaceutical Osteoarthritis Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.28.4 Beijing Tide Pharmaceutical Main Business Overview
13.28.5 Beijing Tide Pharmaceutical Latest Developments
13.29 Jiangsu Simcere Pharmaceutical
13.29.1 Jiangsu Simcere Pharmaceutical Company Information
13.29.2 Jiangsu Simcere Pharmaceutical Osteoarthritis Analgesics Product Portfolios and Specifications
13.29.3 Jiangsu Simcere Pharmaceutical Osteoarthritis Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.29.4 Jiangsu Simcere Pharmaceutical Main Business Overview
13.29.5 Jiangsu Simcere Pharmaceutical Latest Developments
13.30 Cspc Holdings
13.30.1 Cspc Holdings Company Information
13.30.2 Cspc Holdings Osteoarthritis Analgesics Product Portfolios and Specifications
13.30.3 Cspc Holdings Osteoarthritis Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.30.4 Cspc Holdings Main Business Overview
13.30.5 Cspc Holdings Latest Developments
13.31 Concentric Analgesics
13.31.1 Concentric Analgesics Company Information
13.31.2 Concentric Analgesics Osteoarthritis Analgesics Product Portfolios and Specifications
13.31.3 Concentric Analgesics Osteoarthritis Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
13.31.4 Concentric Analgesics Main Business Overview
13.31.5 Concentric Analgesics Latest Developments
14 Research Findings and Conclusion

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Osteoarthritis Analgesics Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Osteoarthritis Analgesics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Injections
Table 4. Major Players of Oral Medications
Table 5. Major Players of Topical Medications
Table 6. Global Osteoarthritis Analgesics Sales by Type (2020-2025) & (K Units)
Table 7. Global Osteoarthritis Analgesics Sales Market Share by Type (2020-2025)
Table 8. Global Osteoarthritis Analgesics Revenue by Type (2020-2025) & ($ million)
Table 9. Global Osteoarthritis Analgesics Revenue Market Share by Type (2020-2025)
Table 10. Global Osteoarthritis Analgesics Sale Price by Type (2020-2025) & (US$/Unit)
Table 11. Global Osteoarthritis Analgesics Sale by Application (2020-2025) & (K Units)
Table 12. Global Osteoarthritis Analgesics Sale Market Share by Application (2020-2025)
Table 13. Global Osteoarthritis Analgesics Revenue by Application (2020-2025) & ($ million)
Table 14. Global Osteoarthritis Analgesics Revenue Market Share by Application (2020-2025)
Table 15. Global Osteoarthritis Analgesics Sale Price by Application (2020-2025) & (US$/Unit)
Table 16. Global Osteoarthritis Analgesics Sales by Company (2020-2025) & (K Units)
Table 17. Global Osteoarthritis Analgesics Sales Market Share by Company (2020-2025)
Table 18. Global Osteoarthritis Analgesics Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Osteoarthritis Analgesics Revenue Market Share by Company (2020-2025)
Table 20. Global Osteoarthritis Analgesics Sale Price by Company (2020-2025) & (US$/Unit)
Table 21. Key Manufacturers Osteoarthritis Analgesics Producing Area Distribution and Sales Area
Table 22. Players Osteoarthritis Analgesics Products Offered
Table 23. Osteoarthritis Analgesics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Osteoarthritis Analgesics Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Osteoarthritis Analgesics Sales Market Share Geographic Region (2020-2025)
Table 28. Global Osteoarthritis Analgesics Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Osteoarthritis Analgesics Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Osteoarthritis Analgesics Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Osteoarthritis Analgesics Sales Market Share by Country/Region (2020-2025)
Table 32. Global Osteoarthritis Analgesics Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Osteoarthritis Analgesics Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Osteoarthritis Analgesics Sales by Country (2020-2025) & (K Units)
Table 35. Americas Osteoarthritis Analgesics Sales Market Share by Country (2020-2025)
Table 36. Americas Osteoarthritis Analgesics Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Osteoarthritis Analgesics Sales by Type (2020-2025) & (K Units)
Table 38. Americas Osteoarthritis Analgesics Sales by Application (2020-2025) & (K Units)
Table 39. APAC Osteoarthritis Analgesics Sales by Region (2020-2025) & (K Units)
Table 40. APAC Osteoarthritis Analgesics Sales Market Share by Region (2020-2025)
Table 41. APAC Osteoarthritis Analgesics Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Osteoarthritis Analgesics Sales by Type (2020-2025) & (K Units)
Table 43. APAC Osteoarthritis Analgesics Sales by Application (2020-2025) & (K Units)
Table 44. Europe Osteoarthritis Analgesics Sales by Country (2020-2025) & (K Units)
Table 45. Europe Osteoarthritis Analgesics Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Osteoarthritis Analgesics Sales by Type (2020-2025) & (K Units)
Table 47. Europe Osteoarthritis Analgesics Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Osteoarthritis Analgesics Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Osteoarthritis Analgesics Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Osteoarthritis Analgesics Sales by Type (2020-2025) & (K Units)
Table 51. Middle East & Africa Osteoarthritis Analgesics Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Osteoarthritis Analgesics
Table 53. Key Market Challenges & Risks of Osteoarthritis Analgesics
Table 54. Key Industry Trends of Osteoarthritis Analgesics
Table 55. Osteoarthritis Analgesics Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Osteoarthritis Analgesics Distributors List
Table 58. Osteoarthritis Analgesics Customer List
Table 59. Global Osteoarthritis Analgesics Sales Forecast by Region (2026-2031) & (K Units)
Table 60. Global Osteoarthritis Analgesics Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Osteoarthritis Analgesics Sales Forecast by Country (2026-2031) & (K Units)
Table 62. Americas Osteoarthritis Analgesics Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Osteoarthritis Analgesics Sales Forecast by Region (2026-2031) & (K Units)
Table 64. APAC Osteoarthritis Analgesics Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Osteoarthritis Analgesics Sales Forecast by Country (2026-2031) & (K Units)
Table 66. Europe Osteoarthritis Analgesics Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Osteoarthritis Analgesics Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Osteoarthritis Analgesics Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Osteoarthritis Analgesics Sales Forecast by Type (2026-2031) & (K Units)
Table 70. Global Osteoarthritis Analgesics Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Osteoarthritis Analgesics Sales Forecast by Application (2026-2031) & (K Units)
Table 72. Global Osteoarthritis Analgesics Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Pfizer Basic Information, Osteoarthritis Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 74. Pfizer Osteoarthritis Analgesics Product Portfolios and Specifications
Table 75. Pfizer Osteoarthritis Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 76. Pfizer Main Business
Table 77. Pfizer Latest Developments
Table 78. Bayer Basic Information, Osteoarthritis Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 79. Bayer Osteoarthritis Analgesics Product Portfolios and Specifications
Table 80. Bayer Osteoarthritis Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Bayer Main Business
Table 82. Bayer Latest Developments
Table 83. Johnson & Johnson Basic Information, Osteoarthritis Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 84. Johnson & Johnson Osteoarthritis Analgesics Product Portfolios and Specifications
Table 85. Johnson & Johnson Osteoarthritis Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 86. Johnson & Johnson Main Business
Table 87. Johnson & Johnson Latest Developments
Table 88. Sanofi Basic Information, Osteoarthritis Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 89. Sanofi Osteoarthritis Analgesics Product Portfolios and Specifications
Table 90. Sanofi Osteoarthritis Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 91. Sanofi Main Business
Table 92. Sanofi Latest Developments
Table 93. Abbott Basic Information, Osteoarthritis Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 94. Abbott Osteoarthritis Analgesics Product Portfolios and Specifications
Table 95. Abbott Osteoarthritis Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 96. Abbott Main Business
Table 97. Abbott Latest Developments
Table 98. GlaxoSmithKline Basic Information, Osteoarthritis Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 99. GlaxoSmithKline Osteoarthritis Analgesics Product Portfolios and Specifications
Table 100. GlaxoSmithKline Osteoarthritis Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 101. GlaxoSmithKline Main Business
Table 102. GlaxoSmithKline Latest Developments
Table 103. TEVA Basic Information, Osteoarthritis Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 104. TEVA Osteoarthritis Analgesics Product Portfolios and Specifications
Table 105. TEVA Osteoarthritis Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 106. TEVA Main Business
Table 107. TEVA Latest Developments
Table 108. Almatica Pharma Basic Information, Osteoarthritis Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 109. Almatica Pharma Osteoarthritis Analgesics Product Portfolios and Specifications
Table 110. Almatica Pharma Osteoarthritis Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 111. Almatica Pharma Main Business
Table 112. Almatica Pharma Latest Developments
Table 113. Astellas Pharma Basic Information, Osteoarthritis Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 114. Astellas Pharma Osteoarthritis Analgesics Product Portfolios and Specifications
Table 115. Astellas Pharma Osteoarthritis Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 116. Astellas Pharma Main Business
Table 117. Astellas Pharma Latest Developments
Table 118. Iroko Pharmaceuticals Basic Information, Osteoarthritis Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 119. Iroko Pharmaceuticals Osteoarthritis Analgesics Product Portfolios and Specifications
Table 120. Iroko Pharmaceuticals Osteoarthritis Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 121. Iroko Pharmaceuticals Main Business
Table 122. Iroko Pharmaceuticals Latest Developments
Table 123. SK Chemicals Basic Information, Osteoarthritis Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 124. SK Chemicals Osteoarthritis Analgesics Product Portfolios and Specifications
Table 125. SK Chemicals Osteoarthritis Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 126. SK Chemicals Main Business
Table 127. SK Chemicals Latest Developments
Table 128. Eli Lilly Basic Information, Osteoarthritis Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 129. Eli Lilly Osteoarthritis Analgesics Product Portfolios and Specifications
Table 130. Eli Lilly Osteoarthritis Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 131. Eli Lilly Main Business
Table 132. Eli Lilly Latest Developments
Table 133. Crystal Genomics Basic Information, Osteoarthritis Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 134. Crystal Genomics Osteoarthritis Analgesics Product Portfolios and Specifications
Table 135. Crystal Genomics Osteoarthritis Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 136. Crystal Genomics Main Business
Table 137. Crystal Genomics Latest Developments
Table 138. Synartro Basic Information, Osteoarthritis Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 139. Synartro Osteoarthritis Analgesics Product Portfolios and Specifications
Table 140. Synartro Osteoarthritis Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 141. Synartro Main Business
Table 142. Synartro Latest Developments
Table 143. Mikasa Seiyaku Basic Information, Osteoarthritis Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 144. Mikasa Seiyaku Osteoarthritis Analgesics Product Portfolios and Specifications
Table 145. Mikasa Seiyaku Osteoarthritis Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 146. Mikasa Seiyaku Main Business
Table 147. Mikasa Seiyaku Latest Developments
Table 148. Daiichi Sankyo Basic Information, Osteoarthritis Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 149. Daiichi Sankyo Osteoarthritis Analgesics Product Portfolios and Specifications
Table 150. Daiichi Sankyo Osteoarthritis Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 151. Daiichi Sankyo Main Business
Table 152. Daiichi Sankyo Latest Developments
Table 153. Taisho Pharmaceutical Basic Information, Osteoarthritis Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 154. Taisho Pharmaceutical Osteoarthritis Analgesics Product Portfolios and Specifications
Table 155. Taisho Pharmaceutical Osteoarthritis Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 156. Taisho Pharmaceutical Main Business
Table 157. Taisho Pharmaceutical Latest Developments
Table 158. Sino Biopharmaceutical Basic Information, Osteoarthritis Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 159. Sino Biopharmaceutical Osteoarthritis Analgesics Product Portfolios and Specifications
Table 160. Sino Biopharmaceutical Osteoarthritis Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 161. Sino Biopharmaceutical Main Business
Table 162. Sino Biopharmaceutical Latest Developments
Table 163. Seikagaku Basic Information, Osteoarthritis Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 164. Seikagaku Osteoarthritis Analgesics Product Portfolios and Specifications
Table 165. Seikagaku Osteoarthritis Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 166. Seikagaku Main Business
Table 167. Seikagaku Latest Developments
Table 168. Novartis Basic Information, Osteoarthritis Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 169. Novartis Osteoarthritis Analgesics Product Portfolios and Specifications
Table 170. Novartis Osteoarthritis Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 171. Novartis Main Business
Table 172. Novartis Latest Developments
Table 173. Horizon Pharma Basic Information, Osteoarthritis Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 174. Horizon Pharma Osteoarthritis Analgesics Product Portfolios and Specifications
Table 175. Horizon Pharma Osteoarthritis Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 176. Horizon Pharma Main Business
Table 177. Horizon Pharma Latest Developments
Table 178. Mylan Basic Information, Osteoarthritis Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 179. Mylan Osteoarthritis Analgesics Product Portfolios and Specifications
Table 180. Mylan Osteoarthritis Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 181. Mylan Main Business
Table 182. Mylan Latest Developments
Table 183. Abiogen Pharma Basic Information, Osteoarthritis Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 184. Abiogen Pharma Osteoarthritis Analgesics Product Portfolios and Specifications
Table 185. Abiogen Pharma Osteoarthritis Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 186. Abiogen Pharma Main Business
Table 187. Abiogen Pharma Latest Developments
Table 188. Shanghai Haohai Biological Technology Basic Information, Osteoarthritis Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 189. Shanghai Haohai Biological Technology Osteoarthritis Analgesics Product Portfolios and Specifications
Table 190. Shanghai Haohai Biological Technology Osteoarthritis Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 191. Shanghai Haohai Biological Technology Main Business
Table 192. Shanghai Haohai Biological Technology Latest Developments
Table 193. Zhejiang ChengYi Pharmaceutical Basic Information, Osteoarthritis Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 194. Zhejiang ChengYi Pharmaceutical Osteoarthritis Analgesics Product Portfolios and Specifications
Table 195. Zhejiang ChengYi Pharmaceutical Osteoarthritis Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 196. Zhejiang ChengYi Pharmaceutical Main Business
Table 197. Zhejiang ChengYi Pharmaceutical Latest Developments
Table 198. Jiangsu Hengrui Medicine Basic Information, Osteoarthritis Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 199. Jiangsu Hengrui Medicine Osteoarthritis Analgesics Product Portfolios and Specifications
Table 200. Jiangsu Hengrui Medicine Osteoarthritis Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 201. Jiangsu Hengrui Medicine Main Business
Table 202. Jiangsu Hengrui Medicine Latest Developments
Table 203. Hunan Jingfeng Pharmaceutical Basic Information, Osteoarthritis Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 204. Hunan Jingfeng Pharmaceutical Osteoarthritis Analgesics Product Portfolios and Specifications
Table 205. Hunan Jingfeng Pharmaceutical Osteoarthritis Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 206. Hunan Jingfeng Pharmaceutical Main Business
Table 207. Hunan Jingfeng Pharmaceutical Latest Developments
Table 208. Beijing Tide Pharmaceutical Basic Information, Osteoarthritis Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 209. Beijing Tide Pharmaceutical Osteoarthritis Analgesics Product Portfolios and Specifications
Table 210. Beijing Tide Pharmaceutical Osteoarthritis Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 211. Beijing Tide Pharmaceutical Main Business
Table 212. Beijing Tide Pharmaceutical Latest Developments
Table 213. Jiangsu Simcere Pharmaceutical Basic Information, Osteoarthritis Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 214. Jiangsu Simcere Pharmaceutical Osteoarthritis Analgesics Product Portfolios and Specifications
Table 215. Jiangsu Simcere Pharmaceutical Osteoarthritis Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 216. Jiangsu Simcere Pharmaceutical Main Business
Table 217. Jiangsu Simcere Pharmaceutical Latest Developments
Table 218. Cspc Holdings Basic Information, Osteoarthritis Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 219. Cspc Holdings Osteoarthritis Analgesics Product Portfolios and Specifications
Table 220. Cspc Holdings Osteoarthritis Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 221. Cspc Holdings Main Business
Table 222. Cspc Holdings Latest Developments
Table 223. Concentric Analgesics Basic Information, Osteoarthritis Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 224. Concentric Analgesics Osteoarthritis Analgesics Product Portfolios and Specifications
Table 225. Concentric Analgesics Osteoarthritis Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 226. Concentric Analgesics Main Business
Table 227. Concentric Analgesics Latest Developments


List of Figures
Figure 1. Picture of Osteoarthritis Analgesics
Figure 2. Osteoarthritis Analgesics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Osteoarthritis Analgesics Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Osteoarthritis Analgesics Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Osteoarthritis Analgesics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Osteoarthritis Analgesics Sales Market Share by Country/Region (2024)
Figure 10. Osteoarthritis Analgesics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Injections
Figure 12. Product Picture of Oral Medications
Figure 13. Product Picture of Topical Medications
Figure 14. Global Osteoarthritis Analgesics Sales Market Share by Type in 2025
Figure 15. Global Osteoarthritis Analgesics Revenue Market Share by Type (2020-2025)
Figure 16. Osteoarthritis Analgesics Consumed in Hospital
Figure 17. Global Osteoarthritis Analgesics Market: Hospital (2020-2025) & (K Units)
Figure 18. Osteoarthritis Analgesics Consumed in Personal
Figure 19. Global Osteoarthritis Analgesics Market: Personal (2020-2025) & (K Units)
Figure 20. Osteoarthritis Analgesics Consumed in Others
Figure 21. Global Osteoarthritis Analgesics Market: Others (2020-2025) & (K Units)
Figure 22. Global Osteoarthritis Analgesics Sale Market Share by Application (2024)
Figure 23. Global Osteoarthritis Analgesics Revenue Market Share by Application in 2025
Figure 24. Osteoarthritis Analgesics Sales by Company in 2025 (K Units)
Figure 25. Global Osteoarthritis Analgesics Sales Market Share by Company in 2025
Figure 26. Osteoarthritis Analgesics Revenue by Company in 2025 ($ millions)
Figure 27. Global Osteoarthritis Analgesics Revenue Market Share by Company in 2025
Figure 28. Global Osteoarthritis Analgesics Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Osteoarthritis Analgesics Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Osteoarthritis Analgesics Sales 2020-2025 (K Units)
Figure 31. Americas Osteoarthritis Analgesics Revenue 2020-2025 ($ millions)
Figure 32. APAC Osteoarthritis Analgesics Sales 2020-2025 (K Units)
Figure 33. APAC Osteoarthritis Analgesics Revenue 2020-2025 ($ millions)
Figure 34. Europe Osteoarthritis Analgesics Sales 2020-2025 (K Units)
Figure 35. Europe Osteoarthritis Analgesics Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Osteoarthritis Analgesics Sales 2020-2025 (K Units)
Figure 37. Middle East & Africa Osteoarthritis Analgesics Revenue 2020-2025 ($ millions)
Figure 38. Americas Osteoarthritis Analgesics Sales Market Share by Country in 2025
Figure 39. Americas Osteoarthritis Analgesics Revenue Market Share by Country (2020-2025)
Figure 40. Americas Osteoarthritis Analgesics Sales Market Share by Type (2020-2025)
Figure 41. Americas Osteoarthritis Analgesics Sales Market Share by Application (2020-2025)
Figure 42. United States Osteoarthritis Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Osteoarthritis Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Osteoarthritis Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Osteoarthritis Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Osteoarthritis Analgesics Sales Market Share by Region in 2025
Figure 47. APAC Osteoarthritis Analgesics Revenue Market Share by Region (2020-2025)
Figure 48. APAC Osteoarthritis Analgesics Sales Market Share by Type (2020-2025)
Figure 49. APAC Osteoarthritis Analgesics Sales Market Share by Application (2020-2025)
Figure 50. China Osteoarthritis Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Osteoarthritis Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Osteoarthritis Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Osteoarthritis Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 54. India Osteoarthritis Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Osteoarthritis Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 56. China Taiwan Osteoarthritis Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Osteoarthritis Analgesics Sales Market Share by Country in 2025
Figure 58. Europe Osteoarthritis Analgesics Revenue Market Share by Country (2020-2025)
Figure 59. Europe Osteoarthritis Analgesics Sales Market Share by Type (2020-2025)
Figure 60. Europe Osteoarthritis Analgesics Sales Market Share by Application (2020-2025)
Figure 61. Germany Osteoarthritis Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 62. France Osteoarthritis Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Osteoarthritis Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Osteoarthritis Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Osteoarthritis Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Osteoarthritis Analgesics Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Osteoarthritis Analgesics Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa Osteoarthritis Analgesics Sales Market Share by Application (2020-2025)
Figure 69. Egypt Osteoarthritis Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Osteoarthritis Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Osteoarthritis Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey Osteoarthritis Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Osteoarthritis Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Osteoarthritis Analgesics in 2025
Figure 75. Manufacturing Process Analysis of Osteoarthritis Analgesics
Figure 76. Industry Chain Structure of Osteoarthritis Analgesics
Figure 77. Channels of Distribution
Figure 78. Global Osteoarthritis Analgesics Sales Market Forecast by Region (2026-2031)
Figure 79. Global Osteoarthritis Analgesics Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global Osteoarthritis Analgesics Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global Osteoarthritis Analgesics Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global Osteoarthritis Analgesics Sales Market Share Forecast by Application (2026-2031)
Figure 83. Global Osteoarthritis Analgesics Revenue Market Share Forecast by Application (2026-2031)